Amedica, a Salt Lake City device maker focused on spine, knee and hip implants, set its IPO terms and now hopes to raise as much as $80.2 million. The company plans to sell up to 5.3 million shares at a price of $13 to $15 apiece.

You can find our previous coverage of Amedica here and here. The company is notable in part because it listed the threat of government healthcare reform as a “risk factor” to its business in its SEC filing. It expects to launch its first spinal-implant products next year.